Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0008442
KCT0008442
Not yet recruiting
未知

Comparison of efficacy and safety of 1-L polyethylene glycol plus ascorbic acid for bowel preparation: a randomized multicenter clinical trial

The Catholic University of Korea, St. Vincent's Hospital0 sites261 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The Catholic University of Korea, St. Vincent's Hospital
Enrollment
261
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •A patient who is deemed to require an endoscopy due to complaints of digestive symptoms and meets all of the following selection criteria:
  • •(1\) Adult males and females between the ages of 19 and 74
  • •(2\) Individuals scheduled to undergo upper/lower gastrointestinal endoscopy
  • •(3\) Body Mass Index (BMI) \= 30
  • •(4\) Voluntarily consents to participate in this clinical trial and signs the consent form.

Exclusion Criteria

  • •Individuals who meet any of the following criteria:
  • •(1\) History of the following surgeries, medical conditions, or comorbidities:
  • •\- Dehydration
  • •\-Colorectal resection
  • •\- Gastrointestinal obstruction (intestinal obstruction, gastrointestinal obstruction, etc.), perforation, or gastric outlet obstruction (gastroparesis, etc.)
  • •\- Inflammatory bowel disease (ulcerative colitis, Crohn's disease, etc.) or toxic megacolon
  • •\- Regular or ongoing use of laxatives or stool softeners, or severe constipation requiring physical intervention (e.g. more than 3 bowel movements per week)
  • •\- Severe cardiac disease (NYHA class 3,4 heart failure, acute coronary artery disease within 24 weeks prior to screening, clinically significant arrhythmias, hypertrophic obstructive cardiomyopathy, valvular heart disease, aortic disease, and peripheral vascular disease)
  • •\- History of cardiac arrest
  • •\- Blood coagulation disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Comparison of Efficacy & Tolerability Of Polyethylene Glycol 4000 Versus Polyethylene Glycol 3350+ Electrolytes for Treatment of excessive stool loading in Children with Functional ConstipatioHealth Condition 1: K590- Constipation
CTRI/2024/03/063855Institute of Medical sciences (IMS) and SUM Hospitalk
Completed
Not Applicable
To find out effect and safety of polyethylene glycol and sodium hyaluronate in patient with dry eye disease
CTRI/2023/02/049510Pt BD Sharma PGIMS Rohtak50
Completed
Not Applicable
Efficacy and tolerability of low-volume polyethylene glycol solution (Moviprep) versus standard polyethylene glycol solution (Niflec) in bowel preparation for colonoscopyBowel preparation for colonoscopy
JPRN-UMIN000011505Department of Endoscopy, Aichi Cancer Center Hospital100
Completed
Phase 4
Investigation of the safety and efficacy of Epolyrec in comparrision to Eprex in the management of renal anemia.ESRD patients on hemodialysis.Chronic kidney disease, stage 5
IRCT2014120120172N1otarkib Biopharmaceutical Co.160
Not yet recruiting
Not Applicable
Efficacy and Safety of 1L Polyethylene Glycol plus Low-dose Ascorbic Acid Compared to D-Sorbitol and Picosulfate plus Ascorbic AcidFactors influencing health status and contact with health services
KCT0009000Chung-Ang Univerisity Hospital200